By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Private equity firm Linden LLC has paid an undisclosed sum to purchase the Hycor Biomedical business of Agilent Technologies.

Hycor, which specializes in allergy, autoimmune, and urinalysis diagnostics, became part of Agilent through that firm's 2007 acquisition of Stratagene. Hycor had only been part of Stratagene for a few years before the deal with Agilent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.